Posted in | News | Nuclear Power

Nuclear Power Plant in Finland to Get ABB Upgrade

ABB, the leading power and automation technology group, has won an order from the Finnish power producer TVO for power solutions to enhance reliability and ensure trouble-free and safe operations at the Olkiluoto 1 and 2 nuclear power plant units.

“ABB has best-in-class technologies, significant domain expertise and extensive experience in the power generation domain,” said Franz-Josef Mengede, head of the global Power Generation business, a part of ABB’s Power Systems division. “We are delighted that TVO has entrusted us with the electrical upgrade of this nuclear power plant.”

As part of the order, ABB will replace the low-voltage switchgear and supply a range of power products including the MNS switchgear, high efficiency RESIBLOC distribution transformers and busbar systems. ABB is also responsible for dismantling the old equipment, as well as installing and commissioning the replacement solutions during scheduled annual maintenance outages.

“The renewal of low-voltage switchgear and distribution transformers is part of the plant’s continuous long-term development,” said Janne Mokka, TVO’s Senior Vice President for Technology. “Our objective is to keep the plant units safe, up to date, reliable and competitive in terms of the production costs. We are very satisfied to work with a competitive expert in delivering this significant nuclear power application.”

ABB is a leader in power and automation technologies that enable utility and industry customers to improve performance while lowering environmental impact. The ABB Group of companies operates in around 100 countries and employs about 120,000 people.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.